Tower Research Capital LLC (Trc) Revolution Medicines, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,619 shares of RVMD stock, worth $312,937. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,619
Previous 71,534
93.54%
Holding current value
$312,937
Previous $2.63 Million
91.83%
% of portfolio
0.01%
Previous 0.07%
Shares
22 transactions
Others Institutions Holding RVMD
# of Institutions
357Shares Held
195MCall Options Held
2.66MPut Options Held
945K-
Vanguard Group Inc Valley Forge, PA15.7MShares$1.06 Billion0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA14.6MShares$991 Million2.96% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$908 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X011.4MShares$769 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA9.81MShares$665 Million0.08% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $5.94B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...